Wealth Preservation Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$393K Buy
+1,503
New +$385K 0.19% 63
2026
Q2
– Sell
-785
Closed -$171K – 92
2026
Q1
$171K Sell
785
-735
-48% -$163K 0.14% 74
2025
Q4
$347K Buy
1,520
+80
+6% +$18.2K 0.17% 62
2025
Q3
$333K Buy
1,440
+709
+97% +$144K 0.19% 59
2025
Q2
$136K Buy
731
+230
+46% +$42.7K 0.08% 109
2025
Q1
$105K Buy
+501
New +$97.4K 0.08% 117

Other funds holding ABBV

Wealth Preservation Advisors's ABBV Position: Q3 2026 in Review

Wealth Preservation Advisors opened a new position in AbbVie (ABBV) in Q3 2026: 1,503 shares worth $393K. The stake represents 0.19% of the portfolio and ranks #63 among its holdings. This is a return to the name: Wealth Preservation Advisors previously reported a position in ABBV as recently as Q1 2026.

Wealth Preservation Advisors first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 3,342 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Wealth Preservation Advisors held 1,503 shares of AbbVie worth $393K as of Q3 2026.
  • AbbVie was a new Wealth Preservation Advisors position in Q3 2026.
  • AbbVie made up 0.19% of Wealth Preservation Advisors's portfolio in Q3 2026, its #63 holding.
  • Wealth Preservation Advisors first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • 3,342 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Wealth Preservation Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.